David L. Johnson was elected President and CEO of the Central Indiana Corporate Partnership (CICP) in December 2012. CICP is a unique strategic collaboration of business and philanthropic foundation CEOs and university presidents organized to develop strategies and carry out initiatives, investments and projects that advance regional prosperity. Since 2005, Johnson has also served as President and CEO of CICP’s BioCrossroads life sciences initiative, which Johnson co-founded with other community leaders in 2003.
BioCrossroads is a market-based enterprise focused on strategic collaborations and investments for growing Indiana’s substantial life sciences sector. Among its many activities, BioCrossroads informs and educates; has raised and invests in two capital and two early stage venture capital funds in promising new companies; and builds collaborations of key partners from academia and industry. The most recent collaboration led by BioCrossroads is the Indiana Biosciences Research Institute, inspired and initially capitalized by leading industry, philanthropic and University stakeholders, as well as the State of Indiana. Overall, through his work at BioCrossroads, Johnson has been responsible for raising over $350 million dollars in philanthropic, corporate and venture capital funding.
Johnson is an honors graduate of Harvard University, Harvard Law School and Oxford University, where he studied as a Rhodes Scholar.